Chemistry:Clotiazepam

From HandWiki
Revision as of 21:46, 5 February 2024 by NBrushPhys (talk | contribs) (simplify)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Clotiazepam
Clotiazepam structure.svg
Clotiazepam3d.png
Clinical data
Trade namesVeratran, Rize, Clozan
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral, sublingual, liquid drops
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability~90%
MetabolismHepatic
Elimination half-life4 hours[1]
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC16H15ClN2OS
Molar mass318.82 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)
Clotiazepam pills sold in France as Vératran

Clotiazepam[2] (marketed under brand name Clozan, Distensan, Trecalmo, Rize, Rizen and Veratran) is a thienodiazepine drug which is a benzodiazepine analog. The clotiazepam molecule differs from benzodiazepines in that the benzene ring has been replaced by a thiophene ring.[3] It possesses anxiolytic,[4] skeletal muscle relaxant,[5] anticonvulsant, sedative properties.[6] Stage 2 NREM sleep is significantly increased by clotiazepam.[7]

Indications

Clotiazepam has been trialed and found to be effective in the short-term management of anxiety.[8] Clotiazepam is also used as a premedicant in minor surgery in France and Japan , where the drug is commercially available under the brand names Veratran and Rize, respectively.[9][10]

Pharmacokinetics

A cross-over study in six healthy volunteers (median age 28 years) was conducted using single-dose pharmacokinetics of 5 mg clotiazepam drops, oral tablets, and sublingual tablets. The formulations had similar systemic availability. Compared with oral tablets, the sublingual route gave a lower peak concentration and a delayed peak time, while drops gave a greater maximum concentration with a similar peak time. The use of drops is suggested for a more marked initial effect and the sublingual route for easier administration, especially in the elderly.[11]

Pharmacology

Similar to other benzodiazepines clotiazepam has anxiolytic, sedative, hypnotic, amnesic, anticonvulsant and muscle relaxant pharmacological properties.[6] Clotiazepam binds to the benzodiazepine site of the GABAA receptor where it acts as a full agonist; this action results in an enhanced GABA inhibitory effect at the GABAA receptor which results in the pharmacological effects of clotiazepam.[12]

Clotiazepam has a short elimination half-life and is less prone to accumulation after repeated dosing compared to longer-acting benzodiazepine agents. It is metabolised via oxidation.[13] Clotiazepam is metabolised to hydroxy-clotiazepam and desmethyl-clotiazepam. After oral ingestion of a single 5 mg dose of clotiazepam by three healthy volunteers the drug was rapidly absorbed.[14] The elimination half-life of the drug and its metabolites range from 6.5 hours to 18 hours. Clotiazepam is 99 percent bound to plasma protein.[14] In elderly men the elimination half-life is longer and in elderly women the volume of distribution is increased.[15] Individuals with liver impairment have a reduced volume of distribution as well as a reduced total clearance of clotiazepam; renal impairment does not affect the kinetics of clotiazepam.[16]

The dose equivalent to 10 mg diazepam is thought to be between 5 and 10 mg clotiazepam.

Side effects

Side effects experienced with this product will resemble those of other benzodiazepines. Drowsiness and asthenia are common side effects.[17] There has been a report of reversible hepatitis caused by clotiazepam.[18]

Abuse

Clotiazepam is a recognised drug of abuse.[19]

See also

References

  1. ↑ "Clotiazépam". HAS - Direction de l'Evaluation Médicale. Economique et de Santé Publique. 20 May 2015. https://www.has-sante.fr/upload/docs/evamed/CT-14195_VERATRAN_PIC_REEVAL_RI_Avis2_CT14195.pdf. 
  2. ↑ Nakanishi M, Kazuhiko A, Tetsuya T, Shiroki M, "Thieno-(2,3-E)(1,4)diazepin-2-ones", DE patent 2107356, issued 3 May 1978, assigned to Yoshitomi Pharmaceutical Industries, Ltd.
  3. ↑ "Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs". Biological & Pharmaceutical Bulletin 28 (9): 1711–1716. September 2005. doi:10.1248/bpb.28.1711. PMID 16141545. 
  4. ↑ "Autonomic perception and responses in anxiety-inducing situations". Pharmakopsychiatrie, Neuro-Psychopharmakologie 11 (3): 113–120. May 1978. doi:10.1055/s-0028-1094569. PMID 27828. 
  5. ↑ "Effects of psychotropic drugs on the rage responses induced by electrical stimulation of the medial hypothalamus in cats". Japanese Journal of Pharmacology 33 (4): 885–890. August 1983. doi:10.1254/jjp.33.885. PMID 6632385. 
  6. ↑ 6.0 6.1 "Benzodiazepine metabolism: an analytical perspective". Current Drug Metabolism 9 (8): 827–844. October 2008. doi:10.2174/138920008786049258. PMID 18855614. https://zenodo.org/record/1067769. 
  7. ↑ "Effects of thienodiazepine derivatives on human sleep as compared to those of benzodiazepine derivatives". Psychopharmacologia 44 (2): 165–171. October 1975. doi:10.1007/BF00421005. PMID 709. 
  8. ↑ "A clinical and neurophysiological evaluation of clotiazepam, a new thienodiazepine derivative". International Clinical Psychopharmacology 2 (2): 121–128. April 1987. doi:10.1097/00004850-198704000-00005. PMID 2885366. 
  9. ↑ "RIZE TABLETS 5mg". Official Japanese Drug Information Sheet (Kusuri-no-Shiori). February 2016. http://di.mt-pharma.co.jp/file/shiori/s_riz_d_e.doc. 
  10. ↑ "Clotiazepam (Veratran)". French Guide to Medicines. http://www.doctissimo.fr/medicament-VERATRAN.htm. 
  11. ↑ "The pharmacokinetics of clotiazepam after oral and sublingual administration to volunteers". European Journal of Clinical Pharmacology 37 (6): 617–619. 1989. doi:10.1007/BF00562556. PMID 2575522. 
  12. ↑ "Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones". British Journal of Pharmacology 98 (3): 735–740. November 1989. doi:10.1111/j.1476-5381.1989.tb14600.x. PMID 2574062. 
  13. ↑ "Clinical pharmacokinetics of the newer benzodiazepines". Clinical Pharmacokinetics 8 (3): 233–252. 1983. doi:10.2165/00003088-198308030-00003. PMID 6133664. 
  14. ↑ 14.0 14.1 "Electron capture GLC analysis of the thienodiazepine clotiazepam. Preliminary pharmacokinetic studies". Arzneimittel-Forschung 32 (4): 453–455. 1982. PMID 6125154. 
  15. ↑ "Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol". European Journal of Clinical Pharmacology 26 (1): 55–59. 1984. doi:10.1007/BF00546709. PMID 6143670. 
  16. ↑ "Effect of cirrhosis and renal failure on the kinetics of clotiazepam". European Journal of Clinical Pharmacology 30 (1): 89–92. 1986. doi:10.1007/BF00614202. PMID 2872061. 
  17. ↑ "[Multicenter study of the effectiveness and tolerance of clotiazepam in cardiology]". Minerva Cardioangiologica 38 (1–2): 45–49. 1990. PMID 1971433. 
  18. ↑ "Clotiazepam-induced acute hepatitis". Journal of Hepatology 9 (2): 256–259. September 1989. doi:10.1016/0168-8278(89)90060-3. PMID 2572625. 
  19. ↑ "[Studies on identification of drugs of abuse by diode array detection. I. Screening-test and identification of benzodiazepines by HPLC-DAD with ICOS software system]". Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences (111): 47–56. 1993. PMID 7920567. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Clotiazepam&oldid=3325200"